InvestorsHub Logo
icon url

DewDiligence

09/06/16 11:10 AM

#22 RE: DewDiligence #21

CLCD new corporate slide set:

https://t.co/EvjDJv73Cm
icon url

DewDiligence

09/17/16 11:26 AM

#37 RE: DewDiligence #21

Positive secondary endpoints from SAMURAI study: #msg-125220925.
icon url

DewDiligence

11/14/16 9:21 AM

#48 RE: DewDiligence #21

CLCD has enrolled >50% of 2,968 target in SPARTAN phase-3 trial:

http://finance.yahoo.com/news/colucid-pharmaceuticals-provides-spartan-enrollment-130000943.html

Please see #msg-124979400 for related info.